Advertisement

Ads Placeholder
Loading...

Mainz Biomed N.V.

QUCY•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.46
$-0.02(-3.96%)
U.S. Market opens in 52h 32m

Mainz Biomed N.V. (QUCY) Stock Overview

Explore Mainz Biomed N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.7M
P/E Ratio-0.02
EPS (TTM)$-22.36
ROE-4.66%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

QUCY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mainz Biomed N.V. (QUCY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.02 and a market capitalization of 5.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.96%
5-Day Change
-0.50%
1-Month Change
-45.24%
3-Month Change
-42.74%
6-Month Change
-42.74%
Year-to-Date (YTD) Change
-42.74%
1-Year Change
-42.74%
3-Year Change
-42.74%
5-Year Change
-42.74%
All-Time (Max) Change
-42.74%

Contact Information

http://mainzbiomed.com
49 6131 554 2860
Robert Koch Strasse 50, Mainz, NaN, 55129

Company Facts

260 Employees
IPO DateNov 5, 2021
CountryDE
Actively Trading

Frequently Asked Questions